SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-21-000039
Filing Date
2021-05-03
Accepted
2021-05-03 16:05:28
Documents
15
Period of Report
2021-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20210503.htm   iXBRL 8-K 43298
2 EX-99.1 mygn-xq1cy21earningsreleas.htm EX-99.1 309932
  Complete submission text file 0000899923-21-000039.txt   520632

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20210503.xsd EX-101.SCH 2405
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20210503_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20210503_def.xml EX-101.DEF 1631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20210503_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20210503_pre.xml EX-101.PRE 12634
8 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20210503_htm.xml XML 10768
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 21883521
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences